PRGO
Price
$14.71
Change
+$0.57 (+4.03%)
Updated
Feb 4 closing price
Capitalization
2.02B
21 days until earnings call
Intraday BUY SELL Signals
TLPH
Price
$0.80
Change
-$0.07 (-8.05%)
Updated
Feb 4 closing price
Capitalization
37.62M
Intraday BUY SELL Signals
Interact to see
Advertisement

PRGO vs TLPH

Header iconPRGO vs TLPH Comparison
Open Charts PRGO vs TLPHBanner chart's image
Perrigo
Price$14.71
Change+$0.57 (+4.03%)
Volume$2.24M
Capitalization2.02B
Talphera
Price$0.80
Change-$0.07 (-8.05%)
Volume$334.01K
Capitalization37.62M
PRGO vs TLPH Comparison Chart in %
PRGO
Daily Signal:
Gain/Loss:
TLPH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PRGO vs. TLPH commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRGO is a Hold and TLPH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (PRGO: $14.71 vs. TLPH: $0.80)
Brand notoriety: PRGO and TLPH are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PRGO: 66% vs. TLPH: 90%
Market capitalization -- PRGO: $2.02B vs. TLPH: $37.62M
PRGO [@Pharmaceuticals: Generic] is valued at $2.02B. TLPH’s [@Pharmaceuticals: Generic] market capitalization is $37.62M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRGO’s FA Score shows that 1 FA rating(s) are green whileTLPH’s FA Score has 0 green FA rating(s).

  • PRGO’s FA Score: 1 green, 4 red.
  • TLPH’s FA Score: 0 green, 5 red.
According to our system of comparison, PRGO is a better buy in the long-term than TLPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRGO’s TA Score shows that 6 TA indicator(s) are bullish while TLPH’s TA Score has 4 bullish TA indicator(s).

  • PRGO’s TA Score: 6 bullish, 4 bearish.
  • TLPH’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PRGO is a better buy in the short-term than TLPH.

Price Growth

PRGO (@Pharmaceuticals: Generic) experienced а +5.45% price change this week, while TLPH (@Pharmaceuticals: Generic) price change was -19.50% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.90%. For the same industry, the average monthly price growth was -1.59%, and the average quarterly price growth was +12.73%.

Reported Earning Dates

PRGO is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.90% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRGO($2.02B) has a higher market cap than TLPH($37.6M). PRGO YTD gains are higher at: 5.675 vs. TLPH (-30.096). PRGO has higher annual earnings (EBITDA): 598M vs. TLPH (-12.46M). PRGO has more cash in the bank: 432M vs. TLPH (21.3M). TLPH has less debt than PRGO: TLPH (3.37M) vs PRGO (3.65B). PRGO has higher revenues than TLPH: PRGO (4.28B) vs TLPH (28K).
PRGOTLPHPRGO / TLPH
Capitalization2.02B37.6M5,383%
EBITDA598M-12.46M-4,799%
Gain YTD5.675-30.096-19%
P/E Ratio2818.00N/A-
Revenue4.28B28K15,292,857%
Total Cash432M21.3M2,028%
Total Debt3.65B3.37M108,192%
FUNDAMENTALS RATINGS
PRGO vs TLPH: Fundamental Ratings
PRGO
TLPH
OUTLOOK RATING
1..100
7653
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9098
PRICE GROWTH RATING
1..100
6449
P/E GROWTH RATING
1..100
299
SEASONALITY SCORE
1..100
2390

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (35) in the Pharmaceuticals Other industry is in the same range as TLPH (57). This means that PRGO’s stock grew similarly to TLPH’s over the last 12 months.

PRGO's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as TLPH (100). This means that PRGO’s stock grew similarly to TLPH’s over the last 12 months.

PRGO's SMR Rating (90) in the Pharmaceuticals Other industry is in the same range as TLPH (98). This means that PRGO’s stock grew similarly to TLPH’s over the last 12 months.

TLPH's Price Growth Rating (49) in the Pharmaceuticals Other industry is in the same range as PRGO (64). This means that TLPH’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is significantly better than the same rating for TLPH (99). This means that PRGO’s stock grew significantly faster than TLPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PRGOTLPH
RSI
ODDS (%)
Bearish Trend 1 day ago
72%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
59%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
62%
Bullish Trend 15 days ago
78%
Declines
ODDS (%)
Bearish Trend 8 days ago
66%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
55%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PRGO
Daily Signal:
Gain/Loss:
TLPH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HNVIX39.840.86
+2.21%
Heartland Value Plus Institutional
ICISX15.410.25
+1.65%
VY® Columbia Small Cap Value II I
VEVYX48.710.64
+1.33%
Victory Sycamore Established Value Y
FFANX14.36N/A
N/A
Fidelity Asset Manager 40%
OBMCX53.47-1.17
-2.14%
Oberweis Micro-Cap

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with INCR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then INCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
+4.03%
INCR - PRGO
56%
Loosely correlated
-4.77%
SHPH - PRGO
54%
Loosely correlated
-12.50%
AKAN - PRGO
51%
Loosely correlated
+0.86%
INM - PRGO
44%
Loosely correlated
-5.66%
SBFM - PRGO
37%
Loosely correlated
-1.63%
More

TLPH and

Correlation & Price change

A.I.dvisor tells us that TLPH and ALVO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPH and ALVO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPH
1D Price
Change %
TLPH100%
-8.81%
ALVO - TLPH
31%
Poorly correlated
-2.30%
AKBA - TLPH
30%
Poorly correlated
-2.84%
HIMS - TLPH
30%
Poorly correlated
-4.46%
PRGO - TLPH
25%
Poorly correlated
+4.03%
ZOMDF - TLPH
25%
Poorly correlated
+2.29%
More